Guidelines for Diagnosis & Treatment of Malaria in India ... - NVBDCP

More documents

Recommendations

Info

Guidelines for diagnosis and treatment of malariaTable 1. Chloroquine for P. vivax and P. falciparum cases inareas considered to be chloroquine sensitiveNumber of tabletsAge in years Day 1 Day 2 Day 3(10 mg/Kg) (10 mg/Kg) (5 mg/Kg)
Guidelines for diagnosis and treatment of malariaTable 4. ACT (Artesunate + SP) dosage schedule forP. falciparum cases in chloroquine resistant areasAge in years Number of tablets1 st Day 2 nd Day 3 rd Day< 1 AS ½ ½ ½SP ¼ Nil Nil1 – 4 AS 1 1 1SP 1 Nil Nil5 – 8 AS 2 2 2SP 1½ Nil Nil9 – 4 AS 3 3 3SP 2 Nil Nil15 and above AS 4 4 4SP 3 Nil NilAS – Artesunate 50 mg, SP – Sulfadoxine 500 mg + Pyrimethamine 25 mg5. Severe malaria5.1 Clinical featuresSevere manifestations can develop in P. falciparum infectionover a span of time as short as 12 – 24 hours and may lead todeath, if not treated promptly and adequately. Severe malaria ischaracterized by one or more of the following features:• Impaired consciousness/coma• Repeated generalized convulsions• Renal failure (Serum Creatinine >3 mg/dl)• Jaundice (Serum Bilirubin >3 mg/dl)• Severe anaemia (Hb
Page 6 and 7: Guidelines for diagnosis and treatm
Page 24 and 25: -----------------------------------

Guidelines for Diagnosis & Treatment of Malaria in India ... - NVBDCP

Create successful ePaper yourself

Delete template?

Save as template?